Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7053 | 1335 | 33.3 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
390 | 16316 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | POLYPILL | Author keyword | 35 | 67% | 2% | 31 |
2 | CORONARY HEART DISEASE RISK FUNCTIONS | Author keyword | 15 | 88% | 1% | 7 |
3 | REGICOR | Author keyword | 9 | 83% | 0% | 5 |
4 | FRAMINGHAM EQUATION | Author keyword | 8 | 75% | 0% | 6 |
5 | RISK CHART | Author keyword | 4 | 67% | 0% | 4 |
6 | AVON PRIMARY CARE ABORAT | Address | 4 | 75% | 0% | 3 |
7 | CARDIOVASCULAR RISK EQUATIONS | Author keyword | 4 | 75% | 0% | 3 |
8 | CARDIOVASCULAR RISK ESTIMATION | Author keyword | 4 | 75% | 0% | 3 |
9 | EQUIP ATENCIO PRIMARIA SARDENYA | Address | 4 | 75% | 0% | 3 |
10 | FRAMINGHAM RISK FUNCTION | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | POLYPILL | 35 | 67% | 2% | 31 | Search POLYPILL | Search POLYPILL |
2 | CORONARY HEART DISEASE RISK FUNCTIONS | 15 | 88% | 1% | 7 | Search CORONARY+HEART+DISEASE+RISK+FUNCTIONS | Search CORONARY+HEART+DISEASE+RISK+FUNCTIONS |
3 | REGICOR | 9 | 83% | 0% | 5 | Search REGICOR | Search REGICOR |
4 | FRAMINGHAM EQUATION | 8 | 75% | 0% | 6 | Search FRAMINGHAM+EQUATION | Search FRAMINGHAM+EQUATION |
5 | RISK CHART | 4 | 67% | 0% | 4 | Search RISK+CHART | Search RISK+CHART |
6 | CARDIOVASCULAR RISK EQUATIONS | 4 | 75% | 0% | 3 | Search CARDIOVASCULAR+RISK+EQUATIONS | Search CARDIOVASCULAR+RISK+EQUATIONS |
7 | CARDIOVASCULAR RISK ESTIMATION | 4 | 75% | 0% | 3 | Search CARDIOVASCULAR+RISK+ESTIMATION | Search CARDIOVASCULAR+RISK+ESTIMATION |
8 | FRAMINGHAM RISK FUNCTION | 4 | 75% | 0% | 3 | Search FRAMINGHAM+RISK+FUNCTION | Search FRAMINGHAM+RISK+FUNCTION |
9 | FRAMINGHAM | 4 | 23% | 1% | 15 | Search FRAMINGHAM | Search FRAMINGHAM |
10 | CARDIOVASCULAR PREVENTION | 3 | 14% | 2% | 24 | Search CARDIOVASCULAR+PREVENTION | Search CARDIOVASCULAR+PREVENTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 10 YEAR RISK | 28 | 53% | 3% | 37 |
2 | PROCAM | 16 | 48% | 2% | 24 |
3 | FACTOR BURDEN | 13 | 62% | 1% | 13 |
4 | FRAMINGHAM FUNCTION | 12 | 63% | 1% | 12 |
5 | SHEFFIELD TABLE | 10 | 73% | 1% | 8 |
6 | CHD RISK | 8 | 75% | 0% | 6 |
7 | PROSPECTIVE OPEN COHORT | 8 | 42% | 1% | 15 |
8 | POLYPILL | 5 | 41% | 1% | 9 |
9 | RISK FUNCTION | 4 | 47% | 1% | 7 |
10 | SCORE PROJECT | 4 | 56% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review | 2006 | 184 | 26 | 81% |
Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review | 2012 | 43 | 71 | 79% |
Cardiovascular risk assessment: a global perspective | 2015 | 1 | 77 | 58% |
Cross-sectional review of the response and treatment uptake from the NHS Health Checks programme in Stoke on Trent | 2013 | 12 | 9 | 67% |
Cardiovascular risk scores do not account for the effect of treatment: a review | 2011 | 21 | 35 | 66% |
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) | 2012 | 831 | 460 | 4% |
Predicting the risk of coronary heart disease I. The use of conventional risk markers | 2010 | 21 | 32 | 81% |
Prediction of first coronary events with the Framingham score: A systematic review | 2007 | 67 | 43 | 67% |
Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States | 2013 | 17 | 40 | 35% |
New Strategy to Reduce the Global Burden of Stroke | 2015 | 2 | 44 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AVON PRIMARY CARE ABORAT | 4 | 75% | 0.2% | 3 |
2 | EQUIP ATENCIO PRIMARIA SARDENYA | 4 | 75% | 0.2% | 3 |
3 | REDI P CV | 3 | 60% | 0.2% | 3 |
4 | CVD EPIDEMIOL PREVENT HLTH PROMOT | 2 | 67% | 0.1% | 2 |
5 | DOCENCIA PRACT CLIN CV 18 | 2 | 67% | 0.1% | 2 |
6 | UNITAT DOCENT MED FAMILIA GIRONA | 2 | 67% | 0.1% | 2 |
7 | TOULOUSE MONICA PROJECT | 2 | 31% | 0.4% | 5 |
8 | CLIN INCLIVA | 1 | 100% | 0.1% | 2 |
9 | CONSORCI ATENCIO PRIMARIA EIXAMPLE | 1 | 100% | 0.1% | 2 |
10 | EPIDEMIOL POPULAT SCI PUBL HLTH | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165365 | GRP RIESGO CARDIOVASC NUTR//SALUD MARINA//SERV INVEST INNOVAC FORMAC SANITARIA |
2 | 0.0000160535 | IDEAL CARDIOVASCULAR HEALTH//ATAHUALPA//RIC TER IA NEUROVEGETAT MED ESERCIZIO |
3 | 0.0000157968 | STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN |
4 | 0.0000135688 | ACT STUDY//ASPIRIN DOSE//ANTIOXIDANT DEFENSE MECHANISM |
5 | 0.0000133114 | TUFTS CTSI//EXPLAINED VARIATION//FRACTIONAL POLYNOMIALS |
6 | 0.0000098504 | CORONARY ARTERY CALCIUM//CORONARY CALCIUM//CORONARY VESSELS CALCIFICATION |
7 | 0.0000095218 | APPOINTMENT NON ATTENDANCE//EBELTOFT HLTH PROMOT STUDY//MULTIPHASIC SCREENING |
8 | 0.0000094018 | WHO MONICA PROJECT//CORONARY EVENT REGISTER//MONICA PROJECT |
9 | 0.0000071984 | TURKISH SOC CARDIOL//EXECUTIVE STRESS//MINNESOTA CODING |
10 | 0.0000066931 | MICROPOPULATION//MICROPOPULATION MODEL//EXPONENTIAL RISK AVOIDANCE MODELS |